| Remission of myasthenia gravis caused by proteinuria in nephrotic syndrome. | |
| | |
MedLine Citation:
|
PMID: 9390672 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Myasthenia gravis is caused by antibodies against acetylcholine receptors and is treated with inhibition or elimination of antibody production. We report a 43-year-old myasthenic female who was symptomatic until she developed proteinuria from nephrotic syndrome, which caused a marked drop in acetylcholine receptor antibody titer with remission of myasthenia. Treatment of the nephrotic syndrome produced exacerbation of her myasthenia and a rise in antibody level. This patient's improvement is the result of antibody elimination during proteinuria in nephrotic syndrome. |
| | |
Authors:
|
M Almsaddi; T E Bertorini; W Bastnagel |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Muscle & nerve Volume: 20 ISSN: 0148-639X ISO Abbreviation: Muscle Nerve Publication Date: 1997 Dec |
Date Detail:
|
Created Date: 1997-12-23 Completed Date: 1997-12-23 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 7803146 Medline TA: Muscle Nerve Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 1583-6 Citation Subset: IM |
Affiliation:
|
Department of Neurology, University of Tennessee Memphis, 38163, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Antibodies / analysis Female Humans Myasthenia Gravis / complications*, immunology, physiopathology* Nephrotic Syndrome / complications*, urine* Proteinuria / etiology*, physiopathology* Receptors, Cholinergic / immunology Remission, Spontaneous |
| Chemical | |
Reg. No./Substance:
|
0/Antibodies; 0/Receptors, Cholinergic |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Anti-Hu-associated paraneoplastic sensory neuropathy responding to early aggressive immunotherapy: r...
Next Document: Reversible paralysis with status asthmaticus, steroids, and pancuronium: clinical electrophysiologic...